Benzo[a]pyrene inhibits angiogenic factors-induced αvβ3 integrin expression, neovasculogenesis, and angiogenesis in human umbilical vein endothelial cells

Ching Hao Li, Yu Wen Cheng, Yao Teng Hsu, Yu Jeng Hsu, Po Ling Liao, Jaw Jou Kang

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

New blood vessel formation is necessary for the repair of ischemia-damaged tissues. Endothelial cells produce exogenous and endogenous angiogenic factors in the mediation of angiogenesis and neovasculogenesis during neovascularization. Exposure to environmental pollutants may alter proangiogenic capacity or desensitize the responses of endothelial cells to stimulation by basic fibroblast growth factor and vascular endothelial growth factor. Human umbilical vein endothelial cells (HUVECs) were pretreated with benzo[a]pyrene (B[a]P), the major carcinogenic constituent found in tobacco smoke, for 24 h. Neovasculogenesis, migration, and proliferation were evaluated in solvent-treated and B[a]P-treated HUVECs. Endothelial capillary-like tube formation, cell migration, mitogen-activated protein kinase (MAPK) phosphorylation, and integrin expression were reduced in B[a]P-treated HUVECs with angiogenic factor stimulation, in comparison to solvent-treated HUVECs, although cell proliferation and Akt activation remained unaffected. Inhibition of B[a]P-mediated MAPK and neovasculogenesis was significantly rescued by pretreatment with α-naphthoflavone, an aryl hydrocarbon receptor (AhR) antagonist. The B[a]P-mediated inhibition of neovasculogenesis was also rescued in AhR-silenced HUVECs, suggesting the requirement for AhR in B[a]P-associated effects. B[a]P also inhibited angiogenesis in a chorioallantoic membrane assay. We conclude that B[a]P is a potent inhibitor of angiogenesis, and its effects are mediated via AhR-dependent phenotypic changes in B[a]P-treated HUVECs. These findings contribute to an understanding of the involvement of AhR agonists in vasculotoxicity.

Original languageEnglish
Article numberkfq279
Pages (from-to)544-553
Number of pages10
JournalToxicological Sciences
Volume118
Issue number2
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Angiogenesis Inducing Agents
Benzo(a)pyrene
Endothelial cells
Human Umbilical Vein Endothelial Cells
Integrins
Aryl Hydrocarbon Receptors
Mitogen-Activated Protein Kinases
Endothelial Cells
Chorioallantoic Membrane
Environmental Pollutants
Phosphorylation
Tobacco
Blood vessels
Cell proliferation
Fibroblast Growth Factor 2
Smoke
Vascular Endothelial Growth Factor A
Cell Movement
Blood Vessels
Assays

Keywords

  • Angiogenesis
  • Benzo[a]pyrene
  • Endothelial cells
  • Integrins
  • Neovasculogenesis

ASJC Scopus subject areas

  • Toxicology

Cite this

Benzo[a]pyrene inhibits angiogenic factors-induced αvβ3 integrin expression, neovasculogenesis, and angiogenesis in human umbilical vein endothelial cells. / Li, Ching Hao; Cheng, Yu Wen; Hsu, Yao Teng; Hsu, Yu Jeng; Liao, Po Ling; Kang, Jaw Jou.

In: Toxicological Sciences, Vol. 118, No. 2, kfq279, 12.2010, p. 544-553.

Research output: Contribution to journalArticle

@article{5f19339626a94dbaa3fbb9a50ba6ee53,
title = "Benzo[a]pyrene inhibits angiogenic factors-induced αvβ3 integrin expression, neovasculogenesis, and angiogenesis in human umbilical vein endothelial cells",
abstract = "New blood vessel formation is necessary for the repair of ischemia-damaged tissues. Endothelial cells produce exogenous and endogenous angiogenic factors in the mediation of angiogenesis and neovasculogenesis during neovascularization. Exposure to environmental pollutants may alter proangiogenic capacity or desensitize the responses of endothelial cells to stimulation by basic fibroblast growth factor and vascular endothelial growth factor. Human umbilical vein endothelial cells (HUVECs) were pretreated with benzo[a]pyrene (B[a]P), the major carcinogenic constituent found in tobacco smoke, for 24 h. Neovasculogenesis, migration, and proliferation were evaluated in solvent-treated and B[a]P-treated HUVECs. Endothelial capillary-like tube formation, cell migration, mitogen-activated protein kinase (MAPK) phosphorylation, and integrin expression were reduced in B[a]P-treated HUVECs with angiogenic factor stimulation, in comparison to solvent-treated HUVECs, although cell proliferation and Akt activation remained unaffected. Inhibition of B[a]P-mediated MAPK and neovasculogenesis was significantly rescued by pretreatment with α-naphthoflavone, an aryl hydrocarbon receptor (AhR) antagonist. The B[a]P-mediated inhibition of neovasculogenesis was also rescued in AhR-silenced HUVECs, suggesting the requirement for AhR in B[a]P-associated effects. B[a]P also inhibited angiogenesis in a chorioallantoic membrane assay. We conclude that B[a]P is a potent inhibitor of angiogenesis, and its effects are mediated via AhR-dependent phenotypic changes in B[a]P-treated HUVECs. These findings contribute to an understanding of the involvement of AhR agonists in vasculotoxicity.",
keywords = "Angiogenesis, Benzo[a]pyrene, Endothelial cells, Integrins, Neovasculogenesis",
author = "Li, {Ching Hao} and Cheng, {Yu Wen} and Hsu, {Yao Teng} and Hsu, {Yu Jeng} and Liao, {Po Ling} and Kang, {Jaw Jou}",
year = "2010",
month = "12",
doi = "10.1093/toxsci/kfq279",
language = "English",
volume = "118",
pages = "544--553",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Benzo[a]pyrene inhibits angiogenic factors-induced αvβ3 integrin expression, neovasculogenesis, and angiogenesis in human umbilical vein endothelial cells

AU - Li, Ching Hao

AU - Cheng, Yu Wen

AU - Hsu, Yao Teng

AU - Hsu, Yu Jeng

AU - Liao, Po Ling

AU - Kang, Jaw Jou

PY - 2010/12

Y1 - 2010/12

N2 - New blood vessel formation is necessary for the repair of ischemia-damaged tissues. Endothelial cells produce exogenous and endogenous angiogenic factors in the mediation of angiogenesis and neovasculogenesis during neovascularization. Exposure to environmental pollutants may alter proangiogenic capacity or desensitize the responses of endothelial cells to stimulation by basic fibroblast growth factor and vascular endothelial growth factor. Human umbilical vein endothelial cells (HUVECs) were pretreated with benzo[a]pyrene (B[a]P), the major carcinogenic constituent found in tobacco smoke, for 24 h. Neovasculogenesis, migration, and proliferation were evaluated in solvent-treated and B[a]P-treated HUVECs. Endothelial capillary-like tube formation, cell migration, mitogen-activated protein kinase (MAPK) phosphorylation, and integrin expression were reduced in B[a]P-treated HUVECs with angiogenic factor stimulation, in comparison to solvent-treated HUVECs, although cell proliferation and Akt activation remained unaffected. Inhibition of B[a]P-mediated MAPK and neovasculogenesis was significantly rescued by pretreatment with α-naphthoflavone, an aryl hydrocarbon receptor (AhR) antagonist. The B[a]P-mediated inhibition of neovasculogenesis was also rescued in AhR-silenced HUVECs, suggesting the requirement for AhR in B[a]P-associated effects. B[a]P also inhibited angiogenesis in a chorioallantoic membrane assay. We conclude that B[a]P is a potent inhibitor of angiogenesis, and its effects are mediated via AhR-dependent phenotypic changes in B[a]P-treated HUVECs. These findings contribute to an understanding of the involvement of AhR agonists in vasculotoxicity.

AB - New blood vessel formation is necessary for the repair of ischemia-damaged tissues. Endothelial cells produce exogenous and endogenous angiogenic factors in the mediation of angiogenesis and neovasculogenesis during neovascularization. Exposure to environmental pollutants may alter proangiogenic capacity or desensitize the responses of endothelial cells to stimulation by basic fibroblast growth factor and vascular endothelial growth factor. Human umbilical vein endothelial cells (HUVECs) were pretreated with benzo[a]pyrene (B[a]P), the major carcinogenic constituent found in tobacco smoke, for 24 h. Neovasculogenesis, migration, and proliferation were evaluated in solvent-treated and B[a]P-treated HUVECs. Endothelial capillary-like tube formation, cell migration, mitogen-activated protein kinase (MAPK) phosphorylation, and integrin expression were reduced in B[a]P-treated HUVECs with angiogenic factor stimulation, in comparison to solvent-treated HUVECs, although cell proliferation and Akt activation remained unaffected. Inhibition of B[a]P-mediated MAPK and neovasculogenesis was significantly rescued by pretreatment with α-naphthoflavone, an aryl hydrocarbon receptor (AhR) antagonist. The B[a]P-mediated inhibition of neovasculogenesis was also rescued in AhR-silenced HUVECs, suggesting the requirement for AhR in B[a]P-associated effects. B[a]P also inhibited angiogenesis in a chorioallantoic membrane assay. We conclude that B[a]P is a potent inhibitor of angiogenesis, and its effects are mediated via AhR-dependent phenotypic changes in B[a]P-treated HUVECs. These findings contribute to an understanding of the involvement of AhR agonists in vasculotoxicity.

KW - Angiogenesis

KW - Benzo[a]pyrene

KW - Endothelial cells

KW - Integrins

KW - Neovasculogenesis

UR - http://www.scopus.com/inward/record.url?scp=78549242354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78549242354&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfq279

DO - 10.1093/toxsci/kfq279

M3 - Article

C2 - 20876236

AN - SCOPUS:78549242354

VL - 118

SP - 544

EP - 553

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 2

M1 - kfq279

ER -